SCHEMBL6000231

SCHEMBL6000231

Cc1ccc(COc2ccc(-c3csc(CN4CCC(c5cccc(C(=O)O)c5)CC4)n3)cc2)cc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.41
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
GLP1R P43220 8/20 0.38
STAT1 P42224 1/20 0.38
HTR1A P08908 1/20 0.37
HTR1D P28221 1/20 0.37
HTR1B P28222 1/20 0.37
CCR5 P51681 2/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37
CPT2 P23786 1/20 0.36
CPT1A P50416 1/20 0.36
GYS1 P13807 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000774 0.85 MRGPRX4 (0.43) MRGPRX4ALDH1A1KMT2AGLP1R
SCHEMBL5999913 0.85 MRGPRX4 (0.45) MRGPRX4ALDH1A1KMT2AMEN1GLP1R
SCHEMBL6000477 0.82 PTPN2 (0.53) MRGPRX4ALDH1A1KMT2AGLP1RCPT2
SCHEMBL6001162 0.81 MRGPRX4 (0.44) MRGPRX4GLP1RPPARDPPARA
SCHEMBL5999145 0.73 PTPN2 (0.56) MRGPRX4ALDH1A1KMT2AGLP1RCPT2
SCHEMBL5999093 0.69 PTPN2 (0.53) MRGPRX4ALDH1A1KMT2AHTT
SCHEMBL6000399 0.68 PTPN2 (0.55) ALDH1A1KMT2AMEN1CCR5PPARD
Hydrochloric Acid SCHEMBL6000773 0.65 PTPN2 (0.59) ALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL6000737 0.65 PTPN2 (0.59) ALDH1A1KMT2AMEN1
SCHEMBL5585514 0.65 HRH3 (0.48) MRGPRX4ALDH1A1CPT2CPT1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 MRGPRX4 1577/4885ALDH1A1 1733/4885MAPT 4785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.